Transcriptome study of differential expression in schizophrenia

Human Molecular Genetics

Volumn 22, Issue 24, 2013, Pages 5001-5014

  Sanders, Alan R ^a,b   Göring, Harald H H ^c   Duan, Jubao ^a,b   Drigalenko, Eugene I ^c   Moy, Winton ^a   Freda, Jessica ^a   He, Deli ^a   Shi, Jianxin ^d   Gejman, Pablo V ^a,b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; B3GNT2 PROTEIN; BIK PROTEIN; HISTAMINE METHYLTRANSFERASE; HISTONE H2B; HISTONE H2BC; HISTONE H2BD; HISTONE H2BG; HISTONE H2BH; HISTONE H4; HISTONE H4K; MEMBRANE PROTEIN; MICRORNA; MICRORNA 137; POLYPYRIMIDINE TRACT BINDING PROTEIN; POLYPYRIMIDINE TRACT BINDING PROTEIN 3; PROTEIN BCL 2; PROTEIN KINASE C DELTA; PROTEIN S 100; S100A10 PROTEIN; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SYNAPTOBREVIN; SYNAPTOBREVIN 4; SYNAPTOTAGMIN; SYNAPTOTAGMIN 11; SYNTAXIN; SYNTAXIN 6; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTOME; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

ADULT; APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL GROWTH; CLONAL VARIATION; CONTROLLED STUDY; DNA MICROARRAY; EPSTEIN BARR VIRUS; FEMALE; GENE CONTROL; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GRAVES DISEASE; GROWTH RATE; HETEROZYGOSITY; HUMAN; HUMAN CELL; IMMUNITY; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY CONTROL; RHEUMATOID ARTHRITIS; RNA PROCESSING; SCHIZOPHRENIA; VIRUS LOAD;

ADULT; CASE-CONTROL STUDIES; CELL LINE; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE ANNOTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84888155351     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt350     Document Type: Article

References (173)

1. Prince, M., Patel, V., Saxena, S., Maj, M., Maselko, J., Phillips, M.R. and Rahman, A. (2007) No health without mental health. Lancet, 370, 859-877.
2. Wu, E.Q., Birnbaum, H.G., Shi, L., Ball, D.E., Kessler, R.C., Moulis, M. and Aggarwal, J. (2005) The economic burden of schizophrenia in the United States in 2002. J. Clin. Psychiatry, 66, 1122-1129.
3. APA(1994) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). American Psychiatric Press, Washington, DC.
4. McGrath, J., Saha, S., Chant, D. and Welham, J. (2008) Schizophrenia: a concise overview of incidence, prevalence and mortality. Epidemiol. Rev., 30, 67-76.
5. Messias, E.L., Chen, C.Y. and Eaton, W.W. (2007) Epidemiology of schizophrenia: review of findings and myths. Psychiatr. Clin. North Am., 30, 323-338.
6. Leung, A. and Chue, P. (2000) Sex differences in schizophrenia, a review of the literature. Acta Psychiatr. Scand. Suppl., 401, 3-38.
7. Brown, A.S. (2011) The environment and susceptibility to schizophrenia. Prog. Neurobiol., 93, 23-58.
8. Benros, M.E., Nielsen, P.R., Nordentoft, M., Eaton, W.W., Dalton, S.O. and Mortensen, P.B. (2011) Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am. J. Psychiatry, 168, 1303-1310.
9. Cardno, A.G. and Gottesman, I. (2000) Twin studies of schizophrenia: from bow-and-arrow concordances to Star Wars Mx and functional genomics. Am. J. Med. Genet., 97, 12-17.
10. Shi, J., Levinson, D.F., Duan, J., Sanders, A.R., Zheng, Y., Pe'er, I., Dudbridge, F., Holmans, P.A., Whittemore, A.S., Mowry, B.J. et al. (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature, 460, 753-757.
11. Purcell, S.M., Wray, N.R., Stone, J.L., Visscher, P.M., O'Donovan, M.C., Sullivan, P.F. and Sklar, P. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460, 748-752.
12. Stefansson, H., Ophoff, R.A., Steinberg, S., Andreassen, O.A., Cichon, S., Rujescu, D., Werge, T., Pietilainen, O.P., Mors, O., Mortensen, P.B. et al. (2009) Common variants conferring risk of schizophrenia. Nature, 460, 744-747.
13. PGC (2011) Genome-wide association study identifies five new schizophrenia loci. Nat. Genet., 43, 969-976.
14. Wray, N.R. and Visscher, P.M. (2010) Narrowing the boundaries of the genetic architecture of schizophrenia. Schizophr. Bull., 36, 14-23.
15. Ikeda, M., Aleksic, B., Kinoshita, Y., Okochi, T., Kawashima, K., Kushima, I., Ito, Y., Nakamura, Y., Kishi, T., Okumura, T. et al. (2011) Genome-wide association study of schizophrenia in a Japanese population. Biol. Psychiatry, 69, 472-478.
16. Lee, S.H., DeCandia, T.R., Ripke, S., Yang, J., Sullivan, P.F., Goddard, M.E., Keller, M.C., Visscher, P.M. and Wray, N.R. (2012) Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat. Genet., 44, 247-250.
17. Gottesman, I.I. and Shields, J. (1967)Apolygenic theory of schizophrenia. Proc. Natl Acad. Sci. USA, 58, 199-205.
18. Szulwach, K.E., Li, X., Smrt, R.D., Li, Y., Luo, Y., Lin, L., Santistevan, N.J., Li, W., Zhao, X. and Jin, P. (2010) Cross talk between microRNAand epigenetic regulation in adult neurogenesis. J. Cell. Biol., 189, 127-141.
19. Smrt, R.D., Szulwach, K.E., Pfeiffer, R.L., Li, X., Guo, W., Pathania, M., Teng, Z.Q., Luo, Y., Peng, J., Bordey, A. et al. (2010) MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells, 28, 1060-1070.
20. Silber, J., Lim, D.A., Petritsch, C., Persson, A.I., Maunakea, A.K., Yu, M., Vandenberg, S.R., Ginzinger, D.G., James, C.D., Costello, J.F. et al. (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.BMCMed., 6, 14.
21. Schork, A.J., Thompson, W.K., Pham, P., Torkamani, A., Roddey, J.C., Sullivan, P.F., Kelsoe, J.R., O'Donovan, M.C., Furberg, H., Schork, N.J. et al. (2013) All SNPs are not created equal: genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs. PLoS Genet., 9, e1003449.
22. Levinson, D.F., Duan, J., Oh, S., Wang, K., Sanders, A.R., Shi, J., Zhang, N., Mowry, B.J., Olincy, A., Amin, F. et al. (2011) Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions andVIPR2duplications.Am. J. Psychiatry, 168, 302-316.
23. Nicolae, D.L., Gamazon, E., Zhang, W., Duan, S., Dolan, M.E. and Cox, N.J. (2010) Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet., 6, e1000888.
24. Dermitzakis, E.T. (2008)From gene expression to disease risk. Nat. Genet., 40, 492-493.
25. Farber, C.R. and Lusis, A.J. (2008) Integrating global gene expression analysis and genetics. Adv. Genet., 60, 571-601.
26. Montgomery, S.B. and Dermitzakis, E.T. (2009) The resolution of the genetics of gene expression. Hum. Mol. Genet., 18, R211-R215.
27. Gamazon, E.R., Zhang, W., Konkashbaev, A., Duan, S., Kistner, E.O., Nicolae, D.L., Dolan, M.E. and Cox, N.J. (2010) SCAN: SNP and copy number annotation. Bioinformatics, 26, 259-262.
28. Chakravarti, A. and Kapoor, A. (2012) Genetics. Mendelian puzzles. Science, 335, 930-931.
29. Suarez, B.K., Duan, J., Sanders, A.R., Hinrichs, A.L., Jin, C.H., Hou, C., Buccola, N.G., Hale, N., Weilbaecher, A.N., Nertney, D.A. et al. (2006) Genomewide linkage scan of 409 European-Ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am. J. Hum. Genet., 78, 315-333.
30. Sanders, A.R., Duan, J., Levinson, D.F., Shi, J., He, D., Hou, C., Burrell, G.J., Rice, J.P., Nertney, D.A., Olincy, A. et al. (2008) No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am. J. Psychiatry, 165, 497-506.
31. Sanders, A.R., Levinson, D.F., Duan, J., Dennis, J.M., Li, R., Kendler, K.S., Rice, J.P., Shi, J., Mowry, B.J., Amin, F. et al. (2010) The Internet-based MGS2control sample: self-report of mental illness. Am. J. Psychiatry, 167, 854-865.
32. Choy, E., Yelensky, R., Bonakdar, S., Plenge, R.M., Saxena, R., De Jager, P.L., Shaw, S.Y., Wolfish, C.S., Slavik, J.M., Cotsapas, C. et al. (2008) Genetic analysis of humantraits in vitro: drug response and gene expression in lymphoblastoid cell lines. PLoS Genet., 4, e1000287.
33. Caliskan, M., Cusanovich, D.A., Ober, C. and Gilad, Y. (2011) The effects of EBV transformation on gene expression levels and methylation profiles. Hum. Mol. Genet., 20, 1643-1652.
34. Huang da, W., Sherman, B.T. and Lempicki, R.A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc., 4, 44-57.
35. Rossin, E.J., Lage, K., Raychaudhuri, S., Xavier, R.J., Tatar, D., Benita, Y., Cotsapas, C. and Daly, M.J. (2011) Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet., 7, e1001273.
36. Medzhitov, R. and Horng, T. (2009) Transcriptional control of the inflammatory response. Nat. Rev. Immunol., 9, 692-703.
37. Tagai, C., Morita, S., Shiraishi, T., Miyaji, K. and Iwamuro, S. (2011) Antimicrobial properties of arginine- and lysine-rich histones and involvement of bacterial outer membrane protease T in their differential mode of actions. Peptides, 32, 2003-2009.
38. Kim, H.S., Cho, J.H., Park, H.W., Yoon, H., Kim, M.S. and Kim, S.C. (2002) Endotoxin-neutralizing antimicrobial proteins of the human placenta. J. Immunol., 168, 2356-2364.
39. Witkin, S.S., Linhares, I.M., Bongiovanni, A.M., Herway, C. and Skupski, D. (2011) Unique alterations in infection-induced immune activation during pregnancy. BJOG, 118, 145-153.
40. Kawasaki, H. and Iwamuro, S. (2008) Potential roles of histones in host defense as antimicrobial agents. Infect. Disord. Drug. Targets, 8, 195-205.
41. Wiesner, J. and Vilcinskas, A. (2010) Antimicrobial peptides: the ancient arm of the human immune system. Virulence, 1, 440-464.
42. Malik, H.S. and Henikoff, S. (2003) Phylogenomics of the nucleosome. Nat. Struct. Biol., 10, 882-891.
43. Akbarian, S. (2010) Epigenetics of schizophrenia. Curr. Top. Behav. Neurosci., 4, 611-628.
44. Guidotti, A., Auta, J., Chen, Y., Davis, J.M., Dong, E., Gavin, D.P., Grayson, D.R., Matrisciano, F., Pinna, G., Satta, R. et al. (2010) Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology, 60, 1007-1016.
45. Matrisciano, F., Tueting, P., Dalal, I., Kadriu, B., Grayson, D.R., Davis, J.M., Nicoletti, F. and Guidotti, A. (2013) Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice. Neuropharmacology, 68, 184-194.
46. de Jong, S., van Eijk, K.R., Zeegers, D.W., Strengman, E., Janson, E., Veldink, J.H., van den Berg, L.H., Cahn, W., Kahn, R.S., Boks, M.P. et al. (2012) Expression QTL analysis of top loci from GWAS meta-analysis highlights additional schizophrenia candidate genes. Eur. J. Hum. Genet., 20, 1004-1008.
47. Hu, Y., Chopra, V., Chopra, R., Locascio, J.J., Liao, Z., Ding, H., Zheng, B., Matson, W.R., Ferrante, R.J., Rosas, H.D. et al. (2011) Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse. Proc. Natl Acad. Sci. USA, 108, 17141-17146.
48. Voineagu, I., Wang, X., Johnston, P., Lowe, J.K., Tian, Y., Horvath, S., Mill, J., Cantor, R.M., Blencowe, B.J. and Geschwind, D.H. (2011) Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature, 474, 380-384.
49. Eaton, W.W., Byrne, M., Ewald, H., Mors, O., Chen, C.Y., Agerbo, E. and Mortensen, P.B. (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry, 163, 521-528.
50. Eaton, W.W., Pedersen, M.G., Nielsen, P.R. and Mortensen, P.B. (2010) Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord., 12, 638-646.
51. Brown, A.S. and Derkits, E.J. (2010) Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry, 167, 261-280.
52. Laan, W., Grobbee, D.E., Selten, J.P., Heijnen, C.J., Kahn, R.S. and Burger, H. (2010) Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. J. Clin. Psychiatry, 71, 520-527.
53. Horton, R., Wilming, L., Rand, V., Lovering, R.C., Bruford, E.A., Khodiyar, V.K., Lush, M.J., Povey, S., Talbot, C.C. Jr, Wright, M.W. et al. (2004) Gene map of the extended human MHC. Nat. Rev. Genet., 5, 889-899.
54. Sklar, P., Ripke, S., Scott, L.J., Andreassen, O.A., Cichon, S., Craddock, N., Edenberg, H.J., Nurnberger, J.I. Jr, Rietschel, M., Blackwood, D. et al. (2011) Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat. Genet., 43, 977-983.
55. Willour, V.L., Seifuddin, F., Mahon, P.B., Jancic, D., Pirooznia, M., Steele, J., Schweizer, B., Goes, F.S., Mondimore, F.M., Mackinnon, D.F. et al. (2012) A genome-wide association study of attempted suicide. Mol. Psychiatry, 17, 433-444.
56. Neale, B.M., Medland, S.E., Ripke, S., Asherson, P., Franke, B., Lesch, K.P., Faraone, S.V., Nguyen, T.T., Schafer, H., Holmans, P. et al. (2010) Meta-analysis of genome-wide association studies of attention-deficit/ hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry, 49, 884-897.
57. Anney, R., Klei, L., Pinto, D., Regan, R., Conroy, J., Magalhaes, T.R., Correia, C., Abrahams, B.S., Sykes, N., Pagnamenta, A.T. et al. (2010) A genome-wide scan for common alleles affecting risk for autism. Hum. Mol. Genet., 19, 4072-4082.
58. Bierut, L.J., Madden, P.A., Breslau, N., Johnson, E.O., Hatsukami, D., Pomerleau, O.F., Swan, G.E., Rutter, J., Bertelsen, S., Fox, L. et al. (2007) Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum. Mol. Genet., 16, 24-35.
59. Tobacco and Genetics Consortium (2010) Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet., 42, 441-447.
60. Thorgeirsson, T.E., Gudbjartsson, D.F., Surakka, I., Vink, J.M., Amin, N., Geller, F., Sulem, P., Rafnar, T., Esko, T., Walter, S. et al. (2010) Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat. Genet., 42, 448-453.
61. Zuo, L., Zhang, C.K., Wang, F., Li, C.S., Zhao, H., Lu, L., Zhang, X.Y., Zhang, H., Zhang, F., Krystal, J.H. et al. (2011) A novel, functional and replicable risk gene region for alcohol dependence identified by genome-wide association study. PLoS ONE, 6, e26726.
62. Bierut, L.J., Agrawal, A., Bucholz, K.K., Doheny, K.F., Laurie, C., Pugh, E., Fisher, S., Fox, L., Howells, W., Bertelsen, S. et al. (2010) A genome-wide association study of alcohol dependence. Proc. Natl Acad. Sci. USA, 107, 5082-5087.
63. Edenberg, H.J., Koller, D.L., Xuei, X., Wetherill, L., McClintick, J.N., Almasy, L., Bierut, L.J., Bucholz, K.K., Goate, A., Aliev, F. et al. (2010) Genome-wide association study of alcohol dependence implicates a region on chromosome 11. Alcohol. Clin. Exp. Res., 34, 840-852.
64. Schadt, E.E., Monks, S.A., Drake, T.A., Lusis, A.J., Che, N., Colinayo, V., Ruff, T.G., Milligan, S.B., Lamb, J.R., Cavet, G. et al. (2003) Genetics of gene expression surveyed in maize, mouseand man. Nature, 422, 297-302.
65. Yan, H., Yuan, W., Velculescu, V.E., Vogelstein, B. and Kinzler, K.W. (2002) Allelic variation in human gene expression. Science, 297, 1143.
66. Cheung, V.G., Conlin, L.K., Weber, T.M., Arcaro, M., Jen, K.Y., Morley, M. and Spielman, R.S. (2003) Natural variation in human gene expression assessed in lymphoblastoid cells. Nat. Genet., 33, 422-425.
67. Gretarsdottir, S., Thorleifsson, G., Reynisdottir, S.T., Manolescu, A., Jonsdottir, S., Jonsdottir, T., Gudmundsdottir, T., Bjarnadottir, S.M., Einarsson, O.B., Gudjonsdottir, H.M. et al. (2003) The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet., 35, 131-138.
68. Dixon, A.L., Liang, L., Moffatt, M.F., Chen, W., Heath, S., Wong, K.C., Taylor, J., Burnett, E., Gut, I., Farrall, M. et al. (2007) A genome-wide association study of global gene expression. Nat. Genet., 39, 1202-1207.
69. Emilsson, V., Thorleifsson, G., Zhang, B., Leonardson, A.S., Zink, F., Zhu, J., Carlson, S., Helgason, A., Walters, G.B., Gunnarsdottir, S. et al. (2008) Genetics of gene expression and its effect on disease. Nature, 452, 423-428.
70. Petretto, E., Mangion, J., Dickens, N.J., Cook, S.A., Kumaran, M.K., Lu, H., Fischer, J., Maatz, H., Kren, V., Pravenec, M. et al. (2006) Heritability and tissue specificity of expression quantitative trait loci. PLoS Genet., 2, e172.
71. van Heerden, J.H., Conesa, A., Stein, D.J., Montaner, D., Russell, V. and Illing, N. (2009) Parallel changes in gene expression in peripheral blood mononuclear cells and the brain after maternal separation in the mouse. BMC Res. Notes, 2, 195.
72. Gilad, Y., Rifkin, S.A. and Pritchard, J.K. (2008) Revealing the architecture of gene regulation: the promise of eQTL studies. Trends Genet., 24, 408-415.
73. Gerrits, A., Li, Y., Tesson, B.M., Bystrykh, L.V., Weersing, E., Ausema, A., Dontje, B., Wang, X., Breitling, R., Jansen, R.C. et al. (2009) Expression quantitative trait loci are highly sensitive to cellular differentiation state. PLoS Genet., 5, e1000692.
74. Lee, J.H., Park, I.H., Gao, Y., Li, J.B., Li, Z., Daley, G.Q., Zhang, K. and Church, G.M. (2009) A robust approach to identifying tissue-specific gene expression regulatory variants using personalized human induced pluripotent stem cells. PLoS Genet., 5, e1000718.
75. Grundberg, E., Small, K.S., Hedman, A.K., Nica, A.C., Buil, A., Keildson, S., Bell, J.T., Yang, T.P., Meduri, E., Barrett, A. et al. (2012) Mapping cisand trans-regulatory effects across multiple tissues in twins. Nat. Genet., 44, 1084-1089.
76. Fan, Y., Abrahamsen, G., McGrath, J.J. and Mackay-Sim, A. (2012) Altered cell cycle dynamics in schizophrenia. Biol. Psychiatry, 71, 129-135.
77. Lange, C., Huttner, W.B. and Calegari, F. (2009) Cdk4/cyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors. Cell Stem Cell, 5, 320-331.
78. Hindley, C. and Philpott, A. (2012) Co-ordination of cell cycle and differentiation in the developing nervous system. Biochem. J., 444, 375-382.
79. Brennand, K.J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D. et al. (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature, 473, 221-225.
80. Okada, Y., Terao, C., Ikari, K., Kochi, Y., Ohmura, K., Suzuki, A., Kawaguchi, T., Stahl, E.A., Kurreeman, F.A., Nishida, N. et al. (2012) Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population. Nat. Genet., 44, 511-516.
81. Chen, S.J., Chao, Y.L., Chen, C.Y., Chang, C.M., Wu, E.C., Wu, C.S., Yeh, H.H., Chen, C.H. and Tsai, H.J. (2012) Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br. J. Psychiatry, 200, 374-380.
82. Leucht, S., Burkard, T., Henderson, J., Maj, M. and Sartorius, N. (2007) Physical illness and schizophrenia: a review of the literature. Acta Psychiatr. Scand., 116, 317-333.
83. Gorwood, P., Pouchot, J., Vinceneux, P., Puechal, X., Flipo, R.M., De Bandt, M. and Ades, J. (2004) Rheumatoid arthritis and schizophrenia: a negative association at a dimensional level. Schizophr. Res., 66, 21-29.
84. Gilvarry, C.M., Sham, P.C., Jones, P.B., Cannon, M., Wright, P., Lewis, S.W., Bebbington, P., Toone, B.K. and Murray,R.M. (1996) Family history of autoimmune diseases in psychosis. Schizophr. Res., 19, 33-40.
85. Knott, T.K., Madany, P.A., Faden, A.A., Xu, M., Strotmann, J., Henion, T.R. and Schwarting, G.A. (2012) Olfactory discrimination largely persists in mice with defects in odorant receptor expression and axon guidance. Neural Dev., 7, 17.
86. Santarelli, D.M., Beveridge, N.J., Tooney, P.A. and Cairns, M.J. (2011) Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol. Psychiatry, 69, 180-187.
87. Beveridge, N.J., Gardiner, E., Carroll, A.P., Tooney, P.A. and Cairns, M.J. (2010) Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol. Psychiatry, 15, 1176-1189.
88. Xu, B., Roos, J.L., Levy, S., van Rensburg, E.J., Gogos, J.A. and Karayiorgou, M. (2008) Strong association of de novo copy number mutations with sporadic schizophrenia. Nat. Genet., 40, 880-885.
89. Giraldez, A.J., Cinalli, R.M., Glasner, M.E., Enright, A.J., Thomson, J.M., Baskerville, S., Hammond, S.M., Bartel, D.P. and Schier, A.F. (2005) MicroRNAs regulate brain morphogenesis in zebrafish. Science, 308, 833-838.
90. Cuellar, T.L., Davis, T.H., Nelson, P.T., Loeb, G.B., Harfe, B.D., Ullian, E. and McManus, M.T. (2008) Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration. Proc. Natl Acad. Sci. USA, 105, 5614-5619.
91. Davis, T.H., Cuellar, T.L., Koch, S.M., Barker, A.J., Harfe, B.D., McManus, M.T. and Ullian, E.M. (2008) Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J. Neurosci., 28, 4322-4330.
92. Huang, T., Liu, Y., Huang, M., Zhao, X. and Cheng, L. (2010) Wnt1-cre-mediated conditional loss of Dicer results in malformation of the midbrain and cerebellum and failure of neural crest and dopaminergic differentiation in mice. J. Mol. Cell Biol., 2, 152-163.
93. Im, H.I. and Kenny, P.J. (2012) MicroRNAs in neuronal function and dysfunction. Trends Neurosci., 35, 325-334.
94. Xu, B., Hsu, P.K., Karayiorgou, M. and Gogos, J.A. (2012) MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction. Neurobiol. Dis., 46, 291-301.
95. Goldie, B.J. and Cairns, M.J. (2012) Post-transcriptional trafficking and regulation of neuronal gene expression. Mol. Neurobiol., 45, 99-108.
96. Wright, C., Turner, J.A., Calhoun, V.D. and Perrone-Bizzozero, N. (2013) Potential impact of miR-137 and its targets in schizophrenia. Front. Genet., 4, 58.
97. Zhou, Y.,Wang,J., Lu, X., Song, X., Ye, Y., Zhou, J., Ying, B. andWang,L. (2013) Evaluation of six SNPs of MicroRNA machinery genes and risk of schizophrenia. J. Mol. Neurosci., 49, 594-599.
98. Beveridge, N.J., Santarelli, D.M., Wang, X., Tooney, P.A., Webster, M.J., Weickert, C.S. and Cairns, M.J. (2013) Maturation of the human dorsolateral prefrontal cortex coincides with a dynamic shift in MicroRNA expression. Schizophr. Bull. [Epub ahead of print].
99. Cao, Q., Martinez, M., Zhang, J., Sanders, A.R., Badner, J.A., Cravchik, A., Markey, C.J., Beshah, E., Guroff, J.J., Maxwell, M.E. et al. (1997) Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics, 43, 1-8.
100. Martinez, M., Goldin, L.R., Cao, Q., Zhang, J., Sanders, A.R., Nancarrow, D.J., Taylor, J.M., Levinson, D.F., Kirby, A., Crowe, R.R. et al. (1999) Follow-up studyon a susceptibility locus for schizophrenia onchromosome 6q. Am. J. Med. Genet., 88, 337-343.
101. Lewis, C.M., Levinson, D.F., Wise, L.H., DeLisi, L.E., Straub, R.E., Hovatta, I., Williams, N.M., Schwab, S.G., Pulver, A.E., Faraone, S.V. et al. (2003) Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am. J. Hum. Genet., 73, 34-48.
102. Duan, J., Martinez, M., Sanders, A.R., Hou, C., Saitou, N., Kitano, T., Mowry, B.J., Crowe, R.R., Silverman, J.M., Levinson, D.F. et al. (2004) Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. Am. J. Hum. Genet., 75, 624-638.
103. Vladimirov, V., Thiselton, D.L., Kuo, P.H., McClay, J., Fanous, A., Wormley, B., Vittum, J., Ribble, R., Moher, B., van den Oord, E. et al. (2007) A region of 35 kb containing the trace amine associate receptor 6 (TAAR6) gene is associated with schizophrenia in the Irish study of high-density schizophrenia families. Mol. Psychiatry, 12, 842-853.
104. Pae, C.U., Yu, H.S., Amann, D., Kim, J.J., Lee, C.U., Lee, S.J., Jun, T.Y., Lee, C., Paik, I.H., Patkar, A.A. et al. (2008) Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case-control sample. J. Psychiatr. Res., 42, 35-40.
105. Chambers, K.J., Tonkin, L.A., Chang, E., Shelton, D.N., Linskens, M.H. and Funk, W.D. (1998) Identification and cloning of a sequence homologue of dopamine beta-hydroxylase. Gene, 218, 111-120.
106. Pratscher, B., Friedrich, C., Goger, W., Allen, M., Fink, D., Thallinger, C., Wolschek, M., Frei, K., Schofer, C., Pehamberger, H. et al. (2008) Characterization of NKIP: a novel, Na+/K+-ATPase interacting protein mediates neural differentiation and apoptosis. Exp. Cell Res., 314, 463-477.
107. Straub, R.E., Jiang, Y., MacLean, C.J., Ma, Y., Webb, B.T., Myakishev, M.V., Harris-Kerr, C., Wormley, B., Sadek, H., Kadambi, B. et al. (2002) Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet., 71, 337-348.
108. Svenningsson, P., Chergui, K., Rachleff, I., Flajolet, M., Zhang, X., El Yacoubi, M., Vaugeois, J.M., Nomikos, G.G. and Greengard, P. (2006) Alterations in 5-HT1B receptor function by p11 in depression-like states. Science, 311, 77-80.
109. Svenningsson, P. and Greengard, P. (2007) P11 (S100A10)-an inducible adaptor protein that modulates neuronal functions. Curr. Opin. Pharmacol., 7, 27-32.
110. Zhang, L., Su, T.P., Choi, K., Maree, W., Li, C.T., Chung, M.Y., Chen, Y.S., Bai, Y.M., Chou, Y.H., Barker, J.L. et al. (2011) P11 (S100A10) as a potential biomarker of psychiatric patients at risk of suicide. J. Psychiatr. Res., 45, 435-441.
111. Zhang, L., Li, C.T., Su, T.P., Hu, X.Z., Lanius, R.A., Webster, M.J., Chung, M.Y., Chen, Y.S., Bai, Y.M., Barker, J.L. et al. (2011) P11 expression and PET in bipolar disorders. J. Psychiatr. Res., 45, 1426-1431.
112. Pihlstrom, L., Axelsson, G., Bjornara, K.A., Dizdar, N., Fardell, C., Forsgren, L., Holmberg, B., Larsen, J.P., Linder, J., Nissbrandt, H. et al. (2013) Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease. Neurobiol. Aging, 34, 1708.e1707-e1713.
113. Sharma, M., Ioannidis, J.P., Aasly, J.O., Annesi, G., Brice, A., Van Broeckhoven, C., Bertram, L., Bozi, M., Crosiers, D., Clarke, C. et al. (2012) Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology, 79, 659-667.
114. Lill, C.M., Roehr, J.T., McQueen, M.B., Kavvoura, F.K., Bagade, S., Schjeide, B.M., Schjeide, L.M., Meissner, E., Zauft, U., Allen, N.C. et al. (2012) Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet., 8, e1002548.
115. Nalls, M.A., Plagnol, V., Hernandez, D.G., Sharma, M., Sheerin, U.M., Saad, M., Simon-Sanchez, J., Schulte, C., Lesage, S., Sveinbjornsdottir, S. et al. (2011) Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet, 377, 641-649.
116. Yokota, H., Tsujita, T., Okazaki, Y., Kikuya, E. and Oishi, M. (2003) Polymorphic 33-bp repeats with promoter-like activity in synaptotagmin 11 gene. DNA Res., 10, 287-289.
117. Inoue, S., Imamura, A., Okazaki, Y., Yokota, H., Arai, M., Hayashi, N., Furukawa, A., Itokawa, M. and Oishi, M. (2007) Synaptotagmin XI as a candidate gene for susceptibility to schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet., 144B, 332-340.
118. Yeo, H., Kim, H.W., Mo, J., Lee, D., Han, S., Hong, S., Koh, M.J., Sun, W., Choi, S., Rhyu, I.J. et al. (2012) Developmental expression and subcellular distribution of synaptotagmin 11 in rat hippocampus. Neuroscience, 225, 35-43.
119. Heintz, N., Sive, H.L. and Roeder, R.G. (1983) Regulation of human histone gene expression: kinetics of accumulation and changes in the rate of synthesis and in the half-lives of individual histone mRNAs during the HeLa cell cycle. Mol. Cell Biol., 3, 539-550.
120. Shepard, P.J., Choi, E.A., Lu, J., Flanagan, L.A., Hertel, K.J. and Shi, Y. (2011) Complex and dynamic landscape of RNA polyadenylation revealed by PAS-Seq. RNA, 17, 761-772.
121. Marzluff, W.F., Wagner, E.J. and Duronio, R.J. (2008) Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat. Rev. Genet., 9, 843-854.
122. Sugimoto, M., Furuichi, Y., Ide, T. and Goto, M. (1999) Incorrect use of 'immortalization' for B-lymphoblastoid cell lines transformed by Epstein-Barr virus. J. Virol., 73, 9690-9691.
123. Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, e45.
124. Sharp, A.J., Mefford, H.C., Li, K., Baker, C., Skinner, C., Stevenson, R.E., Schroer, R.J., Novara, F., De Gregori, M., Ciccone, R. et al. (2008) A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat. Genet., 40, 322-328.
125. Beaubier, N.T., Hart, A.P., Bartolo, C., Willman, C.L. and Viswanatha, D.S. (2000) Comparison of capillary electrophoresis and polyacrylamide gel electrophoresis for the evaluation of T and B cell clonality by polymerase chain reaction. Diagn. Mol. Pathol., 9, 121-131.
126. Van Gelder, R.N., von Zastrow, M.E., Yool, A., Dement, W.C., Barchas, J.D. and Eberwine, J.H. (1990) Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc. Natl Acad. Sci. USA, 87, 1663-1667.
127. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol., 57, 289-300.
128. Du, P., Kibbe, W.A. and Lin, S.M. (2008) Lumi: a pipeline for processing Illumina microarray. Bioinformatics, 24, 1547-1548.
129. Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A. and Reich, D. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet., 38, 904-909.
130. Goring, H.H., Curran, J.E., Johnson, M.P., Dyer, T.D., Charlesworth, J., Cole, S.A., Jowett, J.B., Abraham, L.J., Rainwater, D.L., Comuzzie, A.G. et al. (2007) Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes. Nat. Genet., 39, 1208-1216.
131. Wyllie, A.H. (2010) 'Where, O death, is thy sting?' A brief review of apoptosis biology. Mol. Neurobiol., 42, 4-9.
132. Chinnadurai, G., Vijayalingam, S. and Rashmi, R. (2008) BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene, 27 (Suppl 1), S20-S29.
133. Sasaki, T., Kitagawa, K., Yagita, Y., Sugiura, S., Omura-Matsuoka, E., Tanaka, S., Matsushita, K., Okano, H., Tsujimoto, Y. and Hori, M. (2006) Bcl2 enhances survival of newborn neurons in the normal and ischemic hippocampus. J. Neurosci. Res., 84, 1187-1196.
134. Sorce, S., Schiavone, S., Tucci, P., Colaianna, M., Jaquet, V., Cuomo, V., Dubois-Dauphin, M., Trabace, L. and Krause, K.H. (2010) The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses. J. Neurosci., 30, 11317-11325.
135. Krystal, J.H., Karper, L.P., Seibyl, J.P., Freeman, G.K., Delaney, R., Bremner, J.D., Heninger, G.R., Bowers, M.B. Jr and Charney, D.S. (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry, 51, 199-214.
136. Sadvakassova, G., Dobocan, M.C., Difalco, M.R. and Congote, L.F. (2009) Regulator of differentiation 1 (ROD1) binds to the amphipathic C-terminal peptide of thrombospondin-4 and is involved in its mitogenic activity. J. Cell Physiol., 220, 672-679.
137. Franken, P., Lopez-Molina, L., Marcacci, L., Schibler, U. and Tafti, M. (2000) The transcription factor DBP affects circadian sleep consolidation and rhythmic EEG activity. J. Neurosci., 20, 617-625.
138. Yang, S., Van Dongen, H.P., Wang, K., Berrettini, W. and Bucan, M. (2009) Assessment of circadian function in fibroblasts of patients with bipolar disorder. Mol. Psychiatry, 14, 143-155.
139. Niculescu, A.B. 3rd, Segal, D.S., Kuczenski, R., Barrett, T., Hauger, R.L. and Kelsoe, J.R. (2000) Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach. Physiol. Genomics, 4, 83-91.
140. Kyosseva, S.V., Elbein, A.D., Hutton, T.L., Griffin, S.T., Mrak, R.E., Sturner, W.Q. and Karson, C.N. (2000) Increased levels of transcription factors Elk-1, cyclic adenosine monophosphate response element-binding protein, and activating transcription factor 2 in the cerebellar vermis of schizophrenic patients. Arch. Gen. Psychiatry, 57, 685-691.
141. Oksenberg, J.R., Baranzini, S.E., Sawcer, S. and Hauser, S.L. (2008) The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat. Rev. Genet., 9, 516-526.
142. Hafler, D.A., Compston, A., Sawcer, S., Lander, E.S., Daly, M.J., De Jager, P.L., de Bakker, P.I., Gabriel, S.B., Mirel, D.B., Ivinson, A.J. et al. (2007) Risk alleles for multiple sclerosis identified by a genome-wide study. N. Engl. J. Med., 357, 851-862.
143. Hoppenbrouwers, I.A., Aulchenko, Y.S., Ebers, G.C., Ramagopalan, S.V., Oostra, B.A., van Duijn, C.M. and Hintzen, R.Q. (2008) EVI5 Is a risk gene for multiple sclerosis. Genes Immun., 9, 334-337.
144. Vestal, D.J. and Jeyaratnam, J.A. (2011) The guanylate-binding proteins: emerging insights into the biochemical properties and functions of this family of large interferon-induced guanosine triphosphatase. J. Interferon Cytokine Res., 31, 89-97.
145. Hu, Y., Wang, J., Yang, B., Zheng, N., Qin, M., Ji, Y., Lin, G., Tian, L., Wu, X., Wu, L. et al. (2011) Guanylate binding protein 4 negatively regulates virus-induced type I IFN and antiviral response by targeting IFN regulatory factor 7. J. Immunol., 187, 6456-6462.
146. Thornalley, P.J. (2003) Glyoxalase I-structure, function and a critical role in the enzymatic defence against glycation. Biochem. Soc. Trans., 31, 1343-1348.
147. Toyosima, M., Maekawa, M., Toyota, T., Iwayama, Y., Arai, M., Ichikawa, T., Miyashita, M., Arinami, T., Itokawa, M. and Yoshikawa, T. (2011) Schizophrenia with the 22q11.2 deletion and additional genetic defects: case history. Br. J. Psychiatry, 199, 245-246.
148. Barua, M., Jenkins, E.C., Chen, W., Kuizon, S., Pullarkat, R.K. and Junaid, M.A. (2011) Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity-implications for autism. Autism Res., 4, 262-270.
149. Kurz, A., Rabbani, N., Walter, M., Bonin, M., Thornalley, P., Auburger, G. and Gispert, S. (2011) Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress. Cell Mol. Life Sci., 68, 721-733.
150. Puffenberger, E.G., Jinks, R.N., Wang, H., Xin, B., Fiorentini, C., Sherman, E.A., Degrazio, D., Shaw, C., Sougnez, C., Cibulskis, K. et al. (2012) A homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder. Hum. Mutat., 33, 1639-1646.
151. Barnes, W.G. and Hough, L.B. (2002) Membrane-bound histamine N-methyltransferase in mouse brain: possible role in the synaptic inactivation of neuronal histamine. J. Neurochem., 82, 1262-1271.
152. Tiligada, E., Kyriakidis, K., Chazot, P.L. and Passani, M.B. (2011) Histamine pharmacology and new CNS drug targets. CNS Neurosci. Ther., 17, 620-628.
153. Oroszi, G., Enoch, M.A., Chun, J., Virkkunen,M. and Goldman, D. (2005) Thr105ile, a functional polymorphismof histamine N-methyltransferase, is associated with alcoholism in two independent populations. Alcohol. Clin. Exp. Res., 29, 303-309.
154. Palada, V., Terzic, J., Mazzulli, J., Bwala, G., Hagenah, J., Peterlin, B., Hung, A.Y., Klein, C. and Krainc, D. (2012) Histamine N-methyltransferase Thr105Ile polymorphism is associated with Parkinson's disease. Neurobiol. Aging, 33, 836.e831.-836.e833.
155. Saetre, P., Emilsson, L., Axelsson, E., Kreuger, J., Lindholm, E. and Jazin, E. (2007)Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry, 7, 46.
156. Arion, D., Unger, T., Lewis, D.A., Levitt, P. and Mirnics, K. (2007) Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol. Psychiatry, 62, 711-721.
157. Pontillo, A., Catamo, E., Arosio, B., Mari, D. and Crovella, S. (2012) NALP1/NLRP1 genetic variants are associated with Alzheimer disease. Alzheimer Dis. Assoc. Disord., 26, 277-281.
158. Sui, J., Li, H., Fang, Y., Liu, Y., Li, M., Zhong, B., Yang, F., Zou, Q. and Wu, Y. (2012) NLRP1 gene polymorphism influences gene transcription and is a risk factor for rheumatoid arthritis in Han Chinese. Arthritis Rheum., 64, 647-654.
159. Kawauchi, T., Shikanai, M. and Kosodo, Y. (2013) Extra-cell cycle regulatory functions of cyclin-dependent kinases (CDK) and CDK inhibitor proteins contribute to brain development and neurological disorders. Genes Cells, 18, 176-194.
160. Nishimura, Y.V., Sekine, K., Chihama, K., Nakajima, K., Hoshino, M., Nabeshima, Y. and Kawauchi, T. (2010) Dissecting the factors involved in the locomotion mode of neuronal migration in the developing cerebral cortex. J. Biol. Chem., 285, 5878-5887.
161. Lang, F., Strutz-Seebohm, N., Seebohm, G. and Lang, U.E. (2010) Significance of SGK1 in the regulation of neuronal function. J. Physiol., 588, 3349-3354.
162. Scales, S.J., Chen, Y.A., Yoo, B.Y., Patel, S.M., Doung, Y.C. and Scheller, R.H. (2000) SNAREs contribute to the specificity of membrane fusion. Neuron, 26, 457-464.
163. Zhang, Y., Shu, L. and Chen, X. (2008) Syntaxin 6, a regulator of the protein trafficking machinery and a target of the p53 family, is required for cell adhesion and survival. J. Biol. Chem., 283, 30689-30698.
164. Hoglinger, G.U., Melhem, N.M., Dickson, D.W., Sleiman, P.M., Wang, L.S., Klei, L., Rademakers, R., de Silva, R., Litvan, I., Riley, D.E. et al. (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat. Genet., 43, 699-705.
165. He, Y., Sun, S., Sha, H., Liu, Z., Yang, L., Xue, Z., Chen, H. and Qi, L. (2010) Emerging roles for XBP1, a sUPeRtranscription factor. Gene Expr., 15, 13-25.
166. Chen, W., Duan, S., Zhou, J., Sun, Y., Zheng, Y., Gu, N., Feng, G. and He, L. (2004) A case-control study provides evidence of association for a functional polymorphism-197C/GinXBP1to schizophrenia and suggests a sex-dependent effect. Biochem. Biophys. Res. Commun., 319, 866-870.
167. Kakiuchi, C., Ishiwata, M., Umekage, T., Tochigi, M., Kohda, K., Sasaki, T. and Kato, T. (2004) Association of the XBP1-116C/G polymorphism with schizophrenia in the Japanese population. Psychiatry Clin. Neurosci., 58, 438-440.
168. Jonsson, E.G., Cichon, S., Schumacher, J., Abou Jamra, R., Schulze, T.G., Deschner, M., Forslund, K., Hall, H., Propping, P., Czerski, P.M. et al. (2006) Association study of a functional promoter polymorphism in the XBP1 gene and schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet., 141B, 71-75.
169. Watanabe, Y., Fukui, N., Muratake, T., Amagane, H., Kaneko, N., Nunokawa, A. and Someya, T. (2006) Association study of a functional promoter polymorphism of the X-box binding protein 1 gene in Japanese patients with schizophrenia. Psychiatry Clin. Neurosci., 60, 633-635.
170. Carter, C.J. (2007) eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia? Schizophr. Bull., 33, 1343-1353.
171. Leckman, J.F., Sholomskas, D., Thompson, W.D., Belanger, A. and Weissman, M.M. (1982) Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch. Gen. Psychiatry, 39, 879-883.
172. Kessler, R.C., Andrews, G., Mroczek, D., Ustun, B. and Wittchen, H.U. (1998) The World Health Organization composite international diagnostic interview short-form (CIDI-SF). Int. J. Methods Psychiatr. Res., 7, 171-185.
173. Nelson, C.B., Kessler, R.C. and Mroczek, D. (2001) Scoring the World Health Organization's Composite International Diagnostic Interview Short Form (CIDI-SF; v1.0 NOV98 for all disorders except OCD which is from v1.1 MAR99). www.hcp.med.harvard.edu/ncs/ftpdir/cidisf_readme.pdf (accessed March 18, 2009).